Source: Virtual Congress 2021 – Asthma inhalers: new devices and adherence



Rating:

Share or cite this content

Citations should be made in the following way:
I. Vähätalo (Seinäjoki and Tampere, Finland), H. Kankaanranta (Seinäjoki, Tampere and Gothenburg, Finland), L. Tuomisto (Seinäjoki and Tampere, Finland), O. Niemelä (Seinäjoki and Tampere, Finland), L. Lehtimäki (Tampere, Finland), P. Ilmarinen (Seinäjoki and Tampere, Finland). Use of short-acting ß2-agonists in patients with adult-onset asthma during 12-years. 3395

Member's Comments

No comment yet.

Related content which might interest you: Oral corticosteroid use in Swedish and Finnish severe asthma patients Source: International Congress 2019 – Asthma treatment: cohorts and real-world studies Year: 2019 12-year adherence to inhaled corticosteroids in adult-onset asthma Source: ERJ Open Res, 6 (1) 00324-2019; 10.1183/23120541.00324-2019 Year: 2020 12-year adherence to inhaled corticosteroids in adult-onset asthma Source: International Congress 2019 – Inhalers: adherence and preference Year: 2019 Re-evaluation of asthma diagnosis in patients with adult-onset asthma Source: International Congress 2017 – New research in asthma and COPD Year: 2017 Variability in asthma severity among steroid-naive patients previously receiving short-acting beta2-agonists Source: Eur Respir J 2003; 22: Suppl. 45, 410s Year: 2003 Use of bisoprolol: comparison of symptoms worsening in patients with asthma and COPD Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of pulmonary diseases Year: 2008 Use of long acting bronchodilators and inhaled corticosteroids within 30-days of discharge in older adults hospitalized for AECOPD Source: International Congress 2015 – Treatment and control of respiratory disease Year: 2015 Once-daily tiotropium respimat add-on to at least ICS maintenance therapy reduces exacerbation risk in patients with uncontrolled symptomatic asthma Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014 Long-term adherence to inhaled corticosteroids and asthma control in adult-onset asthma Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma Year: 2020 Inhaled medication use in asthma and COPD Roma/Gypsies patients Source: Eur Respir J 2005; 26: Suppl. 49, 610s Year: 2005 Inhaled corticosteroids and asthma control in adult-onset asthma: 12-year follow-up study Source: International Congress 2018 – New developments in the treatment of asthma Year: 2018 Use of beta-agonist therapy prior to hospital attendance for severe exacerbations of asthma Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 Survey of dyspnoea in COPD patients on medication and preemptive use of a short-acting β-2 agonist Source: Annual Congress 2009 - Drug effects in COPD Year: 2009 Use of inhaled corticosteroids and the risk of depressive symptoms in patients with chronic obstructive pulmonary disease Source: Virtual Congress 2021 – Lung disease burden and management Year: 2021 Efficacy and safety of inhaled corticosteroids in combination with a long-acting beta2-agonist in asthmatic children under age 5 Source: International Congress 2016 – Drugs, bugs, BMI, and other problems in paediatric asthma Year: 2016 Cessation of long-acting beta2-agonist in children with persistent asthma on inhaled corticosteroids Source: Eur Respir J 2016; 48: 558-560 Year: 2016 Association between inhaled corticosteroid use in COPD and incidence or worsening of type2 diabetes Source: International Congress 2014 – Markers Year: 2014 Prevalence of oral corticosteroid use in the German severe asthma population Source: ERJ Open Res, 5 (4) 00092-2019; 10.1183/23120541.00092-2019 Year: 2019 Use of parenteral long-term bronchodilators in the management of severe and life-threatening asthma Source: Annual Congress 2003 - Recognition, management and assessment of asthma including severe asthma Year: 2003 Add-on effects of long-acting beta2-agonists salmeterol inhaler vs tulobuterol patch in adult patients with mild-to-moderate asthma Source: Annual Congress 2013 –New clinical trials of asthma and COPD drugs Year: 2013